COYS GENK

Active

Private limited companyfounded 2009active for 17 yearsKielstraat 39, 3600 Genk, BelgiumKBO/BCE: BE 0816.559.064

From the official registers: KBO 16 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

COYS GENK has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €2.9m and a net result of €560,003. Equity is growing by about 23% per year across the filed financial years. Its solvency ranks better than 77% of 61 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

COYS GENKActiveChecked score 96/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 29-06-2009 Normal situation
Legal form: Private limited company
Registered office: Kielstraat 39, 3600 Genk
Activity: Specialist medical practice NACE 86220
Establishment unit: 2.182.549.686 3600 Genk, since 01-07-2009
Financial year end: 31 March
Peppol: Reachable since 24-09-2025

Company details

Who decides

Board

DE VOOGHT PieterDirector
VAN HAAFTEN Nienke JantineDirector

Board & ownership

How it is doing

96 Excellent Checked score 2026

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts to 31-03-2026

Gross margin: €769,230; ▲ 4.7%
Turnover: ≈ €1.5m; estimated
Profit: €560,003; ▲ 4.2%
Equity: €2.9m; ▲ 13.5%
Total assets: €3.3m; ▲ 9.7%

2026 accounts 4 days early

Filed on 27-10-2026at the National Bank

Financials

Why 96lowers riskFigures for financial year 2026 (filed 27-10-2026)Sector: Human health activities (NACE 86)Size: total assets €3.3mEquity €2.9m (89.7% of total assets)Show the evidence

Checked score

Score 2026

96 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 71% of its sector peers (NACE 86, small)

Every signal that counts is listed under Signals.

Financial strength · tick = 2025

Strong

Solvency 100=

equity 89.7% of total assets

Liquidity 68+5

short-term debt 7.2% · cash 14.1%

Profitability 90-1

return on assets 17.2%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,078 companies, NACE 86, small)

Last 24 months 11-2024: 0.1%highest value 12-2024: < 0.1%▼ -0.1 percentage points vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value

Credit of up to €280,000 on 30-day terms is acceptable

Liquidity ample (current ratio 12.96, compared with 10.79 in 2025, above the usual 1.5; short-term debt: 7.2% and cash: 14.1% of total assets), and 10.3% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 77% on solvency, 59% on liquidity, 81% on profitability and 68% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Figures for financial year 2026 (filed 27-10-2026)

NBB · annual accounts

Sector: Human health activities (NACE 86)

KBO

Size: total assets €3.3m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Equity €2.9m (89.7% of total assets)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 27-10-2026, 4 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2026

4 days early

2025

2 days early

2024

on the day

2023

5 days early

2022

17 days late

2021

4 days early

2020

11 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 1 day before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 29 October (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-03-2027 year end31-10-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Among the best 9% on equitysector median €594,315 · 61 companies €2.9m View
Positive: 8 profitable years in a rowprofit 2026: €560,003 8 years View
Positive: Filed on time since financial year 2023accounts within the deadline every year 4 years View

Documents

Key facts about COYS GENK

What is the company number of COYS GENK?: 0816.559.064. In Belgium the VAT number is the company number with BE in front: BE 0816.559.064.
Where is COYS GENK based?: The registered office is at Kielstraat 39, 3600 Genk.Company details
What does COYS GENK do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of COYS GENK?: Private limited company (BV).
When was COYS GENK founded?: On 29-06-2009.
Is COYS GENK still active?: Yes, COYS GENK is an active enterprise in the KBO register.
How many employees does COYS GENK have?: On average 0.6 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of COYS GENK?: ≈ €1.5m in financial year 2026. Estimated from the gross margin of €769,230: probably between €1.0m and €2.4m, based on 40 comparable companies, NACE 862.
Is COYS GENK profitable?: In financial year 2026, COYS GENK made a profit of €560,003.
Where can I find the annual accounts of COYS GENK?: COYS GENK filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2026.Annual accounts at the National Bank
When are the next annual accounts of COYS GENK due?: By 31-10-2027, for financial year 2027.Timeline